This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Boyd, D. B. Search for Related Content PubMed PubMed Citation Articles by Boyd, D. B. Social Bookmarking                         What's this?

Insulin and Cancer

239 Glenville Road, Greenwich, CT 06831dbb{at}integrativeoncology.org

Obesity has recently been linked to mortality from the majority of cancers. The insulin/insulin-like growth factor (IGF) system may partly explain this effect. The metabolic syndrome, associated with hyperinsulinemia, may modulate this effect. Recent evidence supports the role of insulin and IGF-1 as important growth factors, acting through the tyrosine kinase growth factor cascade in enhancing tumor cell proliferation. In addition, the metabolic syndrome associated with a chronic inflammatory state and accompanying cytokine abnormalities may also contribute to tumor progression. Growing links between insulin and the etiology as well as prognosis in colon, prostate, pancreatic, and, particularly, breast cancer are reviewed. Of particular concern is the evidence that elevated IGF-1 may interfere with cancer therapy, adversely affecting prognosis. The role of insulin is of concern because of the increasing levels of obesity and the associated metabolic syndrome. Weight gain, through typical Western diet; limited levels of activity; and, more recently, stress-related changes in neuroendocrine function may lead to insulin resistance and hyperinsulinemia. The opportunity for a multidisciplinary approach involving nutrition, exercise, and stress reduction in an integrative setting may be crucial to limiting the insulin-resistant state and improving cancer outcomes.

Key Words: insulin • insulin-like growth factor 1 • obesity • metabolic syndrome • cancer

Integrative Cancer Therapies, Vol. 2, No. 4, 315-329 (2003)
DOI: 10.1177/1534735403259152


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. E. Finstad, A. Emaus, S. Tretli, G. Jasienska, P. T. Ellison, A.-S. Furberg, E. A. Wist, and I. Thune Adult Height, Insulin, and 17{beta}-Estradiol in Young Women Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1477 - 1483. [Abstract] [Full Text] [PDF]

				T. Hickish, G. Astras, P. Thomas, S. Penfold, L. Purandare, T. F. Hickish, and D. Kerr Glucose Intolerance During Adjuvant Chemotherapy for Breast Cancer J Natl Cancer Inst, April 1, 2009; 101(7): 537 - 537. [Full Text] [PDF]

				J. Rodon, V. DeSantos, R. J. Ferry Jr., and R. Kurzrock Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trials Mol. Cancer Ther., September 1, 2008; 7(9): 2575 - 2588. [Abstract] [Full Text] [PDF]

				J. M. W. Wong and D. J. A. Jenkins Carbohydrate Digestibility and Metabolic Effects J. Nutr., November 1, 2007; 137(11): 2539S - 2546S. [Abstract] [Full Text] [PDF]

				Y. Yu, Y. Hao, and L. A. Feig The R-Ras GTPase Mediates Cross Talk between Estrogen and Insulin Signaling in Breast Cancer Cells Mol. Cell. Biol., September 1, 2006; 26(17): 6372 - 6380. [Abstract] [Full Text] [PDF]

				M. F. McCarty and K. I. Block Toward a Core Nutraceutical Program for Cancer Management Integr Cancer Ther, June 1, 2006; 5(2): 150 - 171. [Abstract] [PDF]

				P. J. Goodwin, M. Ennis, I. G. Fantus, K. I. Pritchard, M. E. Trudeau, J. Koo, and N. Hood Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer? J. Clin. Oncol., September 1, 2005; 23(25): 6037 - 6042. [Abstract] [Full Text] [PDF]

				K. Kline, W. Yu, and B. G. Sanders Vitamin E and Breast Cancer J. Nutr., December 1, 2004; 134(12): 3458S - 3462S. [Abstract] [Full Text] [PDF]

				S. S. Daskalopoulou, D. P. Mikhailidis, and M. Elisaf Prevention and Treatment of the Metabolic Syndrome Angiology, November 1, 2004; 55(6): 589 - 612. [Abstract] [PDF]

				S. S. Daskalopoulou, D. P. Mikhailidis, and M. Elisaf Prevention and Treatment of the Metabolic Syndrome Angiology, November 1, 2004; 55(6): 589 - 612. [Abstract] [PDF]

				K. I. Block Integrative Tumor Board: Glioblastoma Multiforme: Integrative Physician's Perspective Integr Cancer Ther, June 1, 2004; 3(2): 170 - 172. [PDF]

				K. I. Block Integrative Tumor Board: Metastatic Renal Cell Carcinoma Integr Cancer Ther, March 1, 2004; 3(1): 44 - 46. [PDF]